MK-2748
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-2748, covering 2015-01-22 to 2015-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1) [Phase 1]